Physician

Madhu Pamganamamula, MD

According to 2025 Medicare claims, Madhu Pamganamamula, MD (NPI: 1699743187) practices internal medicine in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is ODESSA CONSULTANTS, LLC (NPI: 1376729004; TIN: 200201249) and primary practice location at 79761-4537. Pamganamamula is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), participating under the MSSP model.

Pamganamamula's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 194 traditional Medicare patients, billed 12,080 HCPCS/CPT codes, and received $236,237 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,750 prescription claims across 350 beneficiaries totaling $898,207 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 391 claims. Open Payments data shows 21 records totaling $474. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $530,979 to $898,207. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	270	14,183	$261,790
2016	260	26,969	$265,254
2017	255	23,776	$227,073
2018	245	23,985	$246,182
2019	244	22,076	$227,505
2020	252	20,888	$241,659
2021	276	25,849	$317,888
2022	211	19,812	$232,446
2023	194	17,235	$198,903
2024	194	12,080	$236,237

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	279	5,446	$530,979
2016	262	4,465	$472,211
2017	251	4,094	$552,394
2018	267	4,451	$588,413
2019	281	4,601	$648,516
2020	300	6,017	$749,649
2021	359	7,500	$965,359
2022	339	7,437	$1,128,889
2023	332	5,872	$942,834
2024	350	5,750	$898,207

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	183	700	$25,843
2016	146	595	$17,344
2017	108	448	$11,959
2018	180	614	$18,399
2019	195	573	$20,169
2020	229	603	$23,949
2021	138	392	$17,403
2022	136	393	$20,201
2023	109	378	$21,441
2024	140	391	$31,439

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	175	831	$80
84481	Thyroid hormone, t3 measurement, free	158	339	$17
80061	Blood test, lipids (cholesterol and triglycerides)	158	334	$13
84439	Thyroxine (thyroid chemical), free	158	339	$9
36415	Insertion of needle into vein for collection of blood sample	158	412	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	97	3,734	$137,139
Ozempic	Semaglutide	133	4,200	$131,876
Eliquis	Apixaban	68	3,780	$73,412
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	54	2,487	$48,693
Soliqua 100-33	Insulin Glargine/Lixisenatide	35	1,242	$39,463

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	26	$12,234
B4153	Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain), includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$2,921
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	37	$2,420
A7031	Face mask interface, replacement for full face mask, each	N	11	22	$2,221
A7030	Full face mask used with positive airway pressure device, each	N	12	22	$1,929

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$474	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Madhu Pamganamamula, MD?

Tedicare shows public-source Medicare data for Madhu Pamganamamula, MD (NPI 1699743187), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Madhu Pamganamamula, MD have ACO affiliation data?

Madhu Pamganamamula, MD is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098).

What billing organization is linked to Madhu Pamganamamula, MD?

Madhu Pamganamamula, MD is linked to ODESSA CONSULTANTS, LLC (billing NPI 1376729004) in the available physician profile data.

Does Madhu Pamganamamula, MD have Open Payments data?

Madhu Pamganamamula, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.